Company Quick10K Filing
Mateon Therapeutics
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-12-06 Regulation FD, Exhibits
8-K 2019-11-27 Other Events, Exhibits
8-K 2019-11-23 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-11-23 Regulation FD, Exhibits
8-K 2019-11-18 Other Events, Exhibits
8-K 2019-11-01 Enter Agreement, M&A, Sale of Shares, Other Events, Exhibits
8-K 2019-10-29 Regulation FD, Exhibits
8-K 2019-10-23 Other Events, Exhibits
8-K 2019-10-07 Regulation FD, Exhibits
8-K 2019-09-23 Other Events, Exhibits
8-K 2019-09-05 Enter Agreement, Other Events, Exhibits
8-K 2019-09-03 Regulation FD, Exhibits
8-K 2019-08-23 Officers, Exhibits
8-K 2019-08-17 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2019-08-06 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-07-30 Regulation FD, Exhibits
8-K 2019-07-29 Accountant
8-K 2019-07-22 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-07-16 Regulation FD, Exhibits
8-K 2019-07-01 Enter Agreement, Exhibits
8-K 2019-06-14 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-06-10 Regulation FD, Exhibits
8-K 2019-06-04 Regulation FD, Exhibits
8-K 2019-05-30 Officers, Other Events
8-K 2019-04-30 Other Events, Exhibits
8-K 2019-04-22 M&A, Off-BS Arrangement, Sale of Shares, Control, Officers, Amend Bylaw, Other Events, Exhibits
8-K 2019-04-17 Enter Agreement, Sale of Shares, Officers, Other Events, Exhibits
8-K 2019-04-10 Officers
8-K 2018-06-18 Officers, Shareholder Vote, Exhibits
8-K 2018-04-12 Enter Agreement, Sale of Shares, Other Events, Exhibits

Mateon Therapeutics Financials

-

OXGN Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Apollo Education (APOL) 1,063,295 1,955,243 886,324 2,000,328 0 -19,719 98,213 579,272
China Crawfish (CACA) 2 0 0 0 -4 -4 -3
Mirenco (MREO)
Weyland Tech (WEYL) 10,602 5,280 29,462 -958 -4,242 -4,099 -5,303
Lingo Media (LMDC) 1,302 743 0 0 0 0 -0
Granite Real Estate (GRP)
Wewin Group (WWIN) 26 114 5 20 -95 -95 -20
MWF Global (MWF) 0 0 -34 -34 -1
Frontier Digital Media Group (FDMG) 5 31 32 0 -29 -29 -3
Brighthouse Life Insurance Co of Ny (BHNY) 9,065,749 8,029,864 236,819 0 0 2,514 -190,199
G-Mes Holdings (GMES) 1,262 812 652 609 67 141 -31
Baynon (BNON) 11 145 0 0 -21 -20 99
Immune Therapeutics (IMUN) 0 24 12,553 0 34 -5,080 -5,079 -21
Green Planet Bio Engineering (GPLB) 3,001 0 272 0 0 -38 -38 3,001
Blue Sphere (BLSP) 894 43,956 86,868 7,950 2,700 -14,453 -14,295 8,802
Therapeutic Solutions (TSOI) 0 367 1,851 13 10 -1,579 -1,236 481
Stem Holdings (STEMH) 40,803 5,703 958 364 -8,070 -7,496 -5,454
SpringWorks (SWTX)
Clean Coal Technologies (CCTC) 27 16,749 0 0 -5,795 -3,052 894
Ryanair Holdings (RYAA) 13,250,700 8,035,800 0 0 0 0 -34,900

Balance Sheet ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash9,9728,1466,9026,3034,9464,5627,7328,7777,00524,73536,27132,88730,03135,73533,09330,25127,28510,2767,9395,16712,0008,3005,0041,9081,1152331,9661,05862920084
Accounts Receivable
Inventory
PP&E643643644644370371365365304322830279324236268251914268864268268
Assets11,0568,9887,7366,8675,4475,1828,3059,2217,29425,24636,84733,25330,42336,55533,63930,73627,45324,24120,42817,26114,11410,1756,5292,9751,1724372,0991,1497993917,660
Accounts Payable2611385355094164454307334764328493653351891783172874755015323103124013127881,1641,2217729159011,184
Long-Term Debt
Liabilities2,2591,4751,6181,2519018338911,5151,2511,3951,9481,6741,4191,0291,1661,6982,1032,0241,6171,4851,6141,3931,4251,2111,6491,5241,5611,0911,1611,1742,043
Stockholders' Equity8,7977,5136,1185,6164,5464,3497,4147,7066,04323,85134,89931,57929,00435,52632,47329,03825,35022,21718,81115,77612,5008,7825,1041,764-477-1,08753858-362-7835,616
Income Statement ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue09500
Cost of Revenue
Gross Profit
R&D6541,0801,0157466031,1651,1221,3872,3932,2401,6101,6691,9812,4572,9791,9802,3742,0752,3352,8483,0192,8321,77222534295153135364
SG&A
Tax
Net Income-1,891-2,266-2,247-1,880-1,654-2,646-2,097-2,630-3,913-3,450-2,638-2,772-3,324-3,592-3,966-3,325-3,641-3,236-3,453-3,958-3,884-3,536-2,434-7942,100-675-626-633-1,189
Cash Flow ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-2,785-1,984-2,169-1,894-1,448-1,529-2,130-2,624-3,303-908-429-429-464
Cash Investing
Cash Financing9597401,5701,5104,6182,57439320,35414,8390